1028074

Anna Olak-Popko, MD — FEI 3013694321

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warsaw (Poland)

Additional Details

Clinical Investigator (CI)